Summary
Cardio Genomics 2021 is a virtual conference focusing on the promotion of genetic and genomic literacy amongst healthcare professionals. The aim is to promote greater awareness of genomic medicine in cardiology and consequently improve patient care through therapeutic innovation.
Course Director
Professor Perry Elliott, FESC
Chair of the Council on Cardiovascular Genomics, 2019-2022
Who should attend?
- Healthcare practitioners involved in the care and study of patients and populations with cardiovascular disease
- Trainees in cardiology
- Geneticists and genetic trainees with an interest in familial cardiovascular disorders
Abstract presentation
The committee would like to thank all abstract submitters for their contribution to the original science programme.
Selected abstracts will be available via the event's platform (ePoster format) for viewing before, during and after the live event as ePoster.
Three highest-graded abstracts will be presented during the live event in a dedicated session and will be awarded a diploma and a copy of Inherited Cardiac Disease - Oxford Specialist Handbook in Cardiology.
Registration and connection to live event
We are pleased to offer this event for free. However, registration is mandatory.
Registration is now closed for this event.
Connect to live event (registered participants only will be able to access the event).
Scientific Programme
Session 1 - Cardiomyopathies
Presentation | A coming of age for genotyping in Hypertrophic Cardiomyopathies |
Speaker |
Eloisa Arbustini |
Presentation | Therapeutic Implications of genotype in dilated cardiomyopathy |
Speaker |
Yigal Pinto |
Presentation |
The influence of gender on disease phenotypes in cardiomyopathies |
Speaker |
Kristina Haugaa |
Presentation | Live discussion, Q&A |
Speaker |
|
Presentation |
Speaker |
|---|---|
| A coming of age for genotyping in Hypertrophic Cardiomyopathies |
Eloisa Arbustini |
| Therapeutic Implications of genotype in dilated cardiomyopathy |
Yigal Pinto |
|
The influence of gender on disease phenotypes in cardiomyopathies |
Kristina Haugaa |
| Live discussion, Q&A |
|
Session 2 - Arrhythmia
Speaker | Role of genetic testing in the stratification of Brugada Syndrome |
Presentation |
Elijah Behr |
Speaker | How to diagnose and treat long QT syndromes |
Presentation | Stefan Kaab |
Speaker | Genes, ECGs and mortality |
Presentation | Pim van der Harst |
Speaker | Live discussion, Q&A |
Presentation |
Speaker |
Presentation |
|---|---|
| Role of genetic testing in the stratification of Brugada Syndrome |
Elijah Behr |
| How to diagnose and treat long QT syndromes | Stefan Kaab |
| Genes, ECGs and mortality | Pim van der Harst |
| Live discussion, Q&A |
Session 3 - Abstract Presentations
BREAK
Session 4 - Keynote Lecture
Presentation | The clinical value of molecular Autopsy in 2021 |
Speaker | Christopher Semsarian |
Presentation |
Speaker |
|---|---|
| The clinical value of molecular Autopsy in 2021 | Christopher Semsarian |
Session 5 - Vessels
Presentation | When should I consider a genetic test in patients with aortic dissection? |
Speaker |
Bart Loeys |
Presentation | What do populations tell us about stroke? |
Speaker |
Cornelia van Duijn |
Presentation | How should we use genetic risk scores in coronary artery disease? |
Speaker |
Heribert Schunkert |
Presentation | Live discussion, Q&A |
Speaker |
|
Presentation |
Speaker |
|---|---|
| When should I consider a genetic test in patients with aortic dissection? |
Bart Loeys |
| What do populations tell us about stroke? |
Cornelia van Duijn |
| How should we use genetic risk scores in coronary artery disease? |
Heribert Schunkert |
| Live discussion, Q&A |
|
Session 6 - Diagnosis & Treatment
Presentation | The current status of RNA therapeutics in cardiovascular Disease |
Speaker |
Thomas Thum |
Presentation | Genome-wide association studies for cardiovascular disease; clinical perspectives and implications |
Speaker |
Maryam Kavousi |
Presentation | The potential of gene therapy in inherited cardiomyopathies |
Speaker |
Lucie Carrier |
Presentation | Live discussion, Q&A |
Speaker |
Presentation |
Speaker |
|---|---|
| The current status of RNA therapeutics in cardiovascular Disease |
Thomas Thum |
| Genome-wide association studies for cardiovascular disease; clinical perspectives and implications |
Maryam Kavousi |
| The potential of gene therapy in inherited cardiomyopathies |
Lucie Carrier |
| Live discussion, Q&A |
Technical requirements
The conference will be accessible on PC and tablets. The use of a smartphone is not recommended.
A high-speed Internet connection is required (minimum 2 Mbps).
Our mission: To reduce the burden of cardiovascular disease.